AngioDynamics Inc (ANGO) - Cash Flow Conversion Efficiency

Latest as of February 2026: -0.018x

Based on the latest financial reports, AngioDynamics Inc (ANGO) has a cash flow conversion efficiency ratio of -0.018x as of February 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-3.11 Million) by net assets ($173.36 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See AngioDynamics Inc balance sheet quality to measure how much of total assets are equity-financed.

AngioDynamics Inc - Cash Flow Conversion Efficiency Trend (2002–2025)

This chart illustrates how AngioDynamics Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check earnings quality score of AngioDynamics Inc to evaluate the quality of earnings relative to operating cash generation.

AngioDynamics Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of AngioDynamics Inc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Univanich Palm Oil Public Company Limited
BK:UVAN
0.184x
Shanghai Koal Software Co Ltd
SHG:603232
0.000x
Cabaletta Bio Inc
NASDAQ:CABA
-0.412x
Hefei Taihe Optoelectronic
SHG:603656
0.052x
Chengdu Zhimingda Electronics Co. Ltd. A
SHG:688636
-0.030x
Hunan Chen Dian International Development Co Ltd
SHG:600969
0.108x
Tengda Construction Group Co Ltd
SHG:600512
-0.002x
Yingkou Fengguang Advanced Material Co.Ltd.
SHE:301100
N/A

Annual Cash Flow Conversion Efficiency for AngioDynamics Inc (2002–2025)

The table below shows the annual cash flow conversion efficiency of AngioDynamics Inc from 2002 to 2025. For the full company profile with market capitalisation and key ratios, see how much is AngioDynamics Inc worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-05-31 $182.97 Million $-10.13 Million -0.055x +59.59%
2024-05-31 $205.59 Million $-28.16 Million -0.137x -66527.12%
2023-05-31 $378.30 Million $78.00K 0.000x +101.22%
2022-05-31 $424.49 Million $-7.19 Million -0.017x -130.91%
2021-05-31 $439.46 Million $24.09 Million 0.055x +271.73%
2020-05-31 $455.87 Million $-14.55 Million -0.032x -152.43%
2019-05-31 $614.82 Million $37.44 Million 0.061x -19.97%
2018-05-31 $542.60 Million $41.29 Million 0.076x -29.43%
2017-05-31 $517.03 Million $55.74 Million 0.108x +20.90%
2016-05-31 $507.03 Million $45.22 Million 0.089x +89.23%
2015-05-31 $545.02 Million $25.68 Million 0.047x +2.71%
2014-05-31 $537.89 Million $24.68 Million 0.046x -9.30%
2013-05-31 $526.83 Million $26.65 Million 0.051x +128.22%
2012-05-31 $523.39 Million $11.60 Million 0.022x -73.44%
2011-05-31 $405.75 Million $33.87 Million 0.083x -18.25%
2010-05-31 $391.35 Million $39.96 Million 0.102x +90.57%
2009-05-31 $372.19 Million $19.94 Million 0.054x -26.43%
2008-05-31 $355.71 Million $25.91 Million 0.073x +178.55%
2007-05-31 $335.96 Million $8.78 Million 0.026x +0.26%
2006-05-31 $123.44 Million $3.22 Million 0.026x -73.25%
2005-05-31 $49.11 Million $4.79 Million 0.097x +45.20%
2004-05-31 $37.23 Million $2.50 Million 0.067x -85.31%
2003-05-31 $1.49 Million $680.00K 0.457x +111.18%
2002-05-31 $-295.00K $1.21 Million -4.088x --

About AngioDynamics Inc

NASDAQ:ANGO USA Medical Instruments & Supplies
Market Cap
$571.03 Million
Market Cap Rank
#12548 Global
#3132 in USA
Share Price
$13.82
Change (1 day)
-2.81%
52-Week Range
$8.40 - $14.47
All Time High
$30.97
About

AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vessel wall … Read more